Funded Startups in New Jersey
Across the 9 most recent funded entries in New Jersey, the largest disclosed round is Spry’s Series B on 2024-10-09 at $15M, which stands well above most o…
Across the 9 most recent funded entries in New Jersey, the largest disclosed round is Spry’s Series B on 2024-10-09 at $15M, which stands well above most other disclosed amounts on the page (the next-largest disclosed rounds are Carousel Group’s $50M on 2021-04-05 and Cinematic Health Education’s $4M on 2022-06-22, with several smaller disclosed rounds in the $3M–$770K range). A clear temporal edge shows most of the disclosed rounds cluster in 2022–2023, while the most recent activity is concentrated in October 2024 (two rounds: Spry at $15M on 2024-10-09 and The Kennedy Forum at $400K on 2024-10-02).
Sector-wise, Health Care appears in 3 of 9 entries (Spry twice in Series A and Series B; Early Intervention Systems in Seed on 2023-03-13), while “Series Unknown” appears in 3 of 9 entries (The Kennedy Forum at $400K on 2024-10-02; Regenosine at $30K on 2023-02-16; Pangea Natural Foods at $770K on 2023-02-13). The smallest disclosed amount is Regenosine’s $30K on 2023-02-16, creating a wide spread between that low end and the $15M Spry round.
Most recent rounds
9 shownRelated listings
Frequently asked
What’s the largest disclosed round shown for New Jersey, and is it an outlier versus the rest?
The largest disclosed amount in the rows shown is Carousel Group’s $50M (Series A) on 2021-04-05. That $50M level is materially above the next-largest disclosed rounds, including Spry’s $15M (Series B) on 2024-10-09 and Cinematic Health Education’s $4M (Series A) on 2022-06-22.
How concentrated are these rounds in time, based on the 9 most recent entries?
Several rounds land within a tight 2023 window in early February–March: Regenosine ($30K) on 2023-02-16, Pangea Natural Foods ($770K) on 2023-02-13, and Early Intervention Systems ($120K) on 2023-03-13. More recent momentum appears in October 2024 with two entries only one week apart: The Kennedy Forum ($400K) on 2024-10-02 and Spry ($15M) on 2024-10-09.
Which sectors are over-represented in this slice?
Health Care is the only sector appearing at least 3 times: Spry has two disclosed rounds (Series A $7M on 2022-06-22 and Series B $15M on 2024-10-09) plus Early Intervention Systems’ Seed round ($120K) on 2023-03-13. Other sectors in the list—Biotechnology (Regenosine), Food and Beverage (Pangea Natural Foods), Education (Cinematic Health Education), Gaming (Carousel Group), Financial Services (GiveSignup), and Think Tanks (The Kennedy Forum)—appear once each.
What does the stage mix suggest, and how often is the stage undisclosed?
Seed appears once (Early Intervention Systems, $120K on 2023-03-13), and Series A appears in 4 of 9 rows (Cinematic Health Education $4M on 2022-06-22; Spry $7M on 2022-06-22; Carousel Group $50M on 2021-04-05; GiveSignup $3M on 2021-02-24). “Series Unknown” is present in 3 of 9 rows (The Kennedy Forum $400K on 2024-10-02; Regenosine $30K on 2023-02-16; Pangea Natural Foods $770K on 2023-02-13).
Are there low-end outliers that materially differ from the rest of the disclosed amounts?
Yes: Regenosine’s $30K (Series Unknown) on 2023-02-16 is the smallest disclosed amount in the rows shown. It sits below other smaller disclosed entries like Early Intervention Systems’ $120K on 2023-03-13 and The Kennedy Forum’s $400K on 2024-10-02, while the upper end ranges up to Spry’s $15M (2024-10-09) and Carousel Group’s $50M (2021-04-05).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.